Table 2.
RRT N = 16 (%) | No RRT N = 32 (%) | P-value | |
Age | 66.0 | 61.5 | 0.35b |
Female | 2 (13) | 6 (19) | 0.70 |
Hypertension | 5 (31) | 2 (6) | 0.033 |
Diabetes | 8 (50) | 3 (9) | 0.003 |
Creatinine at presentation | 3.8 | 1.6 | 0.064b |
Hematuria (microscopic) | 13 (81) | 27 (84) | 0.99 |
Proteinuria | 0.66 | ||
>3 g/day | 7 (44) | 18 (56) | |
<3 g/day | 7 (44) | 12 (38) | |
NA | 2 (13) | 2 (6) | |
Low complement | 7 (44) | 5 (16) | 0.075 |
Latent period weeks | 2.0 | 4.0 | 0.43b |
Skin lesion | 2 (13) | 11 (34) | 0.17 |
Crescent | 3 (20) | 11 (38) | 0.31 |
Fibrosis | <0.001 | ||
Absent | 0 (0) | 14 (48) | |
1+ | 5 (33) | 13 (45) | |
2+ | 7 (47) | 2 (7) | |
3+ | 3 (20) | 0 (0) |
NA, non available.
Wilcoxon rank-sum test.